Bioprocess Validation Market by End-user, Type and Geography - Forecast and Analysis 2023-2027

Published: Jun 2023 Pages: 157 SKU: IRTNTR75645

Bioprocess Validation Market Analysis Report 2023-2027:

The bioprocess validation market size is estimated to grow at a CAGR of 11.39% between 2022 and 2027. The market size is forecast to increase by USD 280.93 million. The growth of the market depends on several factors, including increasing demand for biopharmaceuticals, increasing need for quality control in pharmaceutical and biotechnology industries, and rising demand for personalized medicine. Factors such as high costs associated with bioprocess validation, the need for highly trained personnel for conducting bioprocess validation, and the lack of standardized protocols and guidelines for bioprocess validation will hamper the growth of the market. Nevertheless, the increasing adoption of single-use technologies, the rising number of drug approvals, and increasing investments in biopharmaceutical manufacturing facilities will propel the growth of the market.

This bioprocess validation market report extensively covers market segmentation by end-user (pharmaceutical companies, contract development and manufacturing organizations, and others), type (in-house and outsourced), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the Size of the Bioprocess Validation Market During the Forecast Period?

To learn more about this report, Request Free Sample

Bioprocess Validation Market: Key Drivers, Trends, Challenges, and Customer Landscape

Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Bioprocess Validation Market Driver

One of the key factors driving the bioprocess validation market growth is the increasing demand for biopharmaceuticals. There is a growing demand for biopharmaceuticals across the healthcare sector and therefore bioprocess has become essential. This validation helps ensure that consistent and high-quality products are produced, which ultimately offers efficacy and safety for patients. component during drug development.

For instance, one of the key examples of where bioprocess validation has a significant impact is in the biomanufacturing of monoclonal antibodies. Hence, a well-designed bioprocess validation plan is the most important element to ensure that the final product meets the necessary regulatory standards and specifications. Similarly, bioprocess plays a significant role in the manufacture of biosimilars. Hence such factors are e expected to drive the bioprocess validation market during the forecast period.

Significant Bioprocess Validation Market Trends

A key factor shaping the bioprocess validation market growth is the increasing adoption of single-use technologies. There is a growing adoption of single-use technologies (SUTs) in bioprocess due to several reasons. The main advantage of SUTs is the ease of implementation for bioprocess validation as the use of SUTs eliminates the need for cleaning and sterilization procedures, which can be time-consuming and costly.

Hence STUs are very advantageous to smaller biotech companies that may not have the resources to invest in extensive cleaning and sterilization equipment. Additionally, one of the main features of STU is that provides greater flexibility in terms of process scale-up and scale-down, as they can be easily disposed of after use. Hence such benefits and applications of single-use technologies in bioprocess is expected to drive the growth of the bioprocess validation market during the forecast period.

Major Bioprocess Validation Market Challenge

High costs associated with bioprocess validation are one of the key challenges hindering the bioprocess validation market growth.  Even though bioprocess validation is a crucial aspect of ensuring the safety and efficacy of biopharmaceutical products., the costs associated with bioprocess validation are high and mainly comprise three main categories: equipment, personnel, and time.

For instance, bioprocess validation needs specialized equipment, such as bioreactors, chromatography systems, and mass spectrometers, among others. These pieces of equipment can be expensive or affordable to acquire, maintain, and calibrate. Hence, the high cost, as well as the initial investment associated with the bioprocess validation equipment, can significantly hinder the growth of the bioprocess validation market during the forecast period.

Key Bioprocess Validation Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Bioprocess Validation Market Customer Landscape

Who are the Major Bioprocess Validation Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Agilent Technologies Inc: The company offers bioprocess validation services called ClinGuide GMP CRISPR sgRNAs for Human Therapeutics system.

The research report also includes detailed analyses of the competitive landscape of the market and information about 20 market vendors, including:

  • Asahi Kasei Corp.
  • Avantor Inc.
  • Bangalore Biotech labs Pvt. Ltd.
  • Charles River Laboratories International Inc.
  • Corning Inc.
  • Danaher Corp.
  • Eurofins Scientific SE
  • GEA Group AG
  • Hangzhou Cobetter Filtration Equipment Co. Ltd.
  • Laboratory Corp. of America Holdings
  • Lonza Group Ltd.
  • Meissner Filtration Products Inc.
  • Merck KGaA
  • Porvair Plc
  • ProPharma Group Holdings LLC
  • Sartorius AG
  • SGS SA
  • Thermo Fisher Scientific Inc.
  • W. L. Gore and Associates Inc.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segments in the Bioprocess Validation Market?

The market share growth by the pharmaceutical companies segment will be significant during the forecast period.  Some of the main classifications of the pharmaceutical companies segment in the bioprocess validation market large players and small and medium-sized enterprises (SMEs).

Get a glance at the market contribution of various segments View the PDF Sample

The pharmaceutical segment was valued at USD 107.57 million in 2017 and continued to grow until 2021. Some prominent pharmaceutical companies such as Pfizer, Johnson, and Johnson (J and J), and Novartis AG (Novartis) have a significant impact on the global bioprocess validation market because of their extensive resources, expertise, and experience in the field. One of the main contributions of large pharmaceutical companies to the bioprocess validation market is the development of innovative and complex biologics. These large enterprises have a robust pipeline of such biologic products, most of which require advanced and sophisticated processes that require thorough validation to ensure product quality, yield, and consistency.  Hence, such factors are expected to drive the growth of this segment which in turn will drive the growth of the bioprocess validation market during the forecast period.

Which are the Key Regions for the Bioprocess Validation Market?

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Some of the key factors which are significantly contributing to the growth of the bioprocess validation market in North America are the rising demand for biopharmaceuticals and the increasing focus on ensuring product safety. Several prominent players such as Pfizer Inc (Pfizer), Merck Group (Merck), Biogen Inc (Biogen), and Amgen Inc (Amgen) are developing biopharmaceuticals and investing in bioprocess validation activities to ensure the quality and safety of their products. Also, regulatory bodies such as the FDA in the US, have strict guidelines mandating the validation of bioprocesses to improve the safety of such processes. Hence, such factors are expected to drive the growth of the bioprocess validation market in the region during the forecast period. 

In 2020, during the COVID-19 pandemic, the growth of the global bioprocess validation market witnessed significant growth as big pharma and biotech companies in the region are pursuing vaccine production, which has led to an increase in the demand for bioprocess validations in the region in North America. However, in 2021, the initiation of large-scale vaccination drives?lifted the lockdown and travel restrictions, which led to the restoration of operations in healthcare units, which further increased the demand for bioprocess validation. Such factors are expected to drive the market during the forecast period.

Segment Overview

The bioprocess validation market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • End-user Outlook (USD Million, 2017 - 2027)
    • Pharmaceutical companies
    • Contract development and manufacturing organizations
    • Others
  • Type Outlook (USD Million, 2017 - 2027)
    • In-house
    • Outsourced
  • Geography Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Australia
      • Argentina
      • Rest of the ROW

Parent Market Analysis

Technavio categorizes the global bioprocess validation market as a part of the global biotechnology market within the overall healthcare industry. The parent global biotechnology market covers products and companies engaged in research and development (R&D) or production of all types of biotechnology products, such as biologics, biosimilars, bio-betters, and biotech reagents. Our market research report has extensively covered external factors influencing the parent market growth during the forecast period.

Bioprocess Validation Market Scope

Report Coverage

Details

Page number

157

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 11.39%

Market growth 2023-2027

USD 280.93 million

Market structure

Fragmented

YoY growth 2022-2023(%)

11.23

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 39%

Key countries

US, Canada, Germany, China, and Japan

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Agilent Technologies Inc., Asahi Kasei Corp., Avantor Inc., Bangalore Biotech labs Pvt. Ltd., Charles River Laboratories International Inc., Corning Inc., Danaher Corp., Eurofins Scientific SE, GEA Group AG, Hangzhou Cobetter Filtration Equipment Co. Ltd., Laboratory Corp. of America Holdings, Lonza Group Ltd., Meissner Filtration Products Inc., Merck KGaA, Porvair Plc, ProPharma Group Holdings LLC, Sartorius AG, SGS SA, Thermo Fisher Scientific Inc., and W. L. Gore and Associates Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Bioprocess Validation Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the market size and its contribution to the market in focus on the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of market vendors

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global bioprocess validation market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global bioprocess validation market 2017 - 2021 ($ million)
    • 4.2 End-user Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.3 Type Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Type Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Pharmaceutical companies - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Pharmaceutical companies - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Pharmaceutical companies - Year-over-year growth 2022-2027 (%)
    • 6.4 Contract development and manufacturing organizations - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Contract development and manufacturing organizations - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Contract development and manufacturing organizations - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Contract development and manufacturing organizations - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Contract development and manufacturing organizations - Year-over-year growth 2022-2027 (%)
    • 6.5 Others - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.6 Market opportunity by End-user
      • Exhibit 46: Market opportunity by End-user ($ million)
      • Exhibit 47: Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Type

    • 7.1 Market segments
      • Exhibit 48: Chart on Type - Market share 2022-2027 (%)
      • Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
    • 7.2 Comparison by Type
      • Exhibit 50: Chart on Comparison by Type
      • Exhibit 51: Data Table on Comparison by Type
    • 7.3 In-house - Market size and forecast 2022-2027
      • Exhibit 52: Chart on In-house - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on In-house - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on In-house - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on In-house - Year-over-year growth 2022-2027 (%)
    • 7.4 Outsourced - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Outsourced - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Outsourced - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Outsourced - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Outsourced - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by Type
      • Exhibit 60: Market opportunity by Type ($ million)
      • Exhibit 61: Data Table on Market opportunity by Type ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 China - Market size and forecast 2022-2027
      • Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.10 Canada - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.11 Japan - Market size and forecast 2022-2027
      • Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ million)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 Agilent Technologies Inc.
              • Exhibit 111: Agilent Technologies Inc. - Overview
              • Exhibit 112: Agilent Technologies Inc. - Business segments
              • Exhibit 113: Agilent Technologies Inc. - Key offerings
              • Exhibit 114: Agilent Technologies Inc. - Segment focus
            • 12.4 Avantor Inc.
              • Exhibit 115: Avantor Inc. - Overview
              • Exhibit 116: Avantor Inc. - Business segments
              • Exhibit 117: Avantor Inc. - Key offerings
              • Exhibit 118: Avantor Inc. - Segment focus
            • 12.5 Bangalore Biotech labs Pvt. Ltd.
              • Exhibit 119: Bangalore Biotech labs Pvt. Ltd. - Overview
              • Exhibit 120: Bangalore Biotech labs Pvt. Ltd. - Product / Service
              • Exhibit 121: Bangalore Biotech labs Pvt. Ltd. - Key offerings
            • 12.6 Charles River Laboratories International Inc.
              • Exhibit 122: Charles River Laboratories International Inc. - Overview
              • Exhibit 123: Charles River Laboratories International Inc. - Business segments
              • Exhibit 124: Charles River Laboratories International Inc. - Key news
              • Exhibit 125: Charles River Laboratories International Inc. - Key offerings
              • Exhibit 126: Charles River Laboratories International Inc. - Segment focus
            • 12.7 Danaher Corp.
              • Exhibit 127: Danaher Corp. - Overview
              • Exhibit 128: Danaher Corp. - Business segments
              • Exhibit 129: Danaher Corp. - Key news
              • Exhibit 130: Danaher Corp. - Key offerings
              • Exhibit 131: Danaher Corp. - Segment focus
            • 12.8 Eurofins Scientific SE
              • Exhibit 132: Eurofins Scientific SE - Overview
              • Exhibit 133: Eurofins Scientific SE - Business segments
              • Exhibit 134: Eurofins Scientific SE - Key news
              • Exhibit 135: Eurofins Scientific SE - Key offerings
              • Exhibit 136: Eurofins Scientific SE - Segment focus
            • 12.9 GEA Group AG
              • Exhibit 137: GEA Group AG - Overview
              • Exhibit 138: GEA Group AG - Business segments
              • Exhibit 139: GEA Group AG - Key offerings
              • Exhibit 140: GEA Group AG - Segment focus
            • 12.10 Hangzhou Cobetter Filtration Equipment Co. Ltd.
              • Exhibit 141: Hangzhou Cobetter Filtration Equipment Co. Ltd. - Overview
              • Exhibit 142: Hangzhou Cobetter Filtration Equipment Co. Ltd. - Product / Service
              • Exhibit 143: Hangzhou Cobetter Filtration Equipment Co. Ltd. - Key offerings
            • 12.11 Laboratory Corp. of America Holdings
              • Exhibit 144: Laboratory Corp. of America Holdings - Overview
              • Exhibit 145: Laboratory Corp. of America Holdings - Business segments
              • Exhibit 146: Laboratory Corp. of America Holdings - Key news
              • Exhibit 147: Laboratory Corp. of America Holdings - Key offerings
              • Exhibit 148: Laboratory Corp. of America Holdings - Segment focus
            • 12.12 Lonza Group Ltd.
              • Exhibit 149: Lonza Group Ltd. - Overview
              • Exhibit 150: Lonza Group Ltd. - Business segments
              • Exhibit 151: Lonza Group Ltd. - Key news
              • Exhibit 152: Lonza Group Ltd. - Key offerings
              • Exhibit 153: Lonza Group Ltd. - Segment focus
            • 12.13 Meissner Filtration Products Inc.
              • Exhibit 154: Meissner Filtration Products Inc. - Overview
              • Exhibit 155: Meissner Filtration Products Inc. - Product / Service
              • Exhibit 156: Meissner Filtration Products Inc. - Key offerings
            • 12.14 Merck KGaA
              • Exhibit 157: Merck KGaA - Overview
              • Exhibit 158: Merck KGaA - Business segments
              • Exhibit 159: Merck KGaA - Key news
              • Exhibit 160: Merck KGaA - Key offerings
              • Exhibit 161: Merck KGaA - Segment focus
            • 12.15 Sartorius AG
              • Exhibit 162: Sartorius AG - Overview
              • Exhibit 163: Sartorius AG - Business segments
              • Exhibit 164: Sartorius AG - Key news
              • Exhibit 165: Sartorius AG - Key offerings
              • Exhibit 166: Sartorius AG - Segment focus
            • 12.16 SGS SA
              • Exhibit 167: SGS SA - Overview
              • Exhibit 168: SGS SA - Business segments
              • Exhibit 169: SGS SA - Key offerings
              • Exhibit 170: SGS SA - Segment focus
            • 12.17 Thermo Fisher Scientific Inc.
              • Exhibit 171: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 172: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 173: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 174: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 175: Thermo Fisher Scientific Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 176: Inclusions checklist
                • Exhibit 177: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 178: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 179: Research methodology
                • Exhibit 180: Validation techniques employed for market sizing
                • Exhibit 181: Information sources
              • 13.5 List of abbreviations
                • Exhibit 182: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              bioprocess validation market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis